Journal of the Egyptian National Cancer Institute (Feb 2022)

Mucinous cystadenocarcinoma of the breast: a new entity with broad differentials—a case report

  • Kanwalpreet Kaur,
  • Ashini Shah,
  • Jahnvi Gandhi,
  • Priti Trivedi

DOI
https://doi.org/10.1186/s43046-022-00112-9
Journal volume & issue
Vol. 34, no. 1
pp. 1 – 5

Abstract

Read online

Abstract Background Mucinous cystadenocarcinoma is a rare and recently described primary breast cancer with strikingly similar histomorphology to ovarian, pancreatic, and gastrointestinal counterparts. The diagnosis cannot be made until the metastatic lesion is ruled out. Case presentation We are reporting the case of a 65-year-old woman with primary mucinous cystadenocarcinoma of the breast while exploring clinicopathological features and approach to diagnosis. Though the immunohistochemistry panel of CK7, CK20, CDX2, SATB2, PAX8, mammoglobin, and GATA3 plays a crucial role in ruling out metastasis but aberrant CK20 positivity was seen in our case, the final diagnosis was made after a complete radiological workup. We also noted strong membranous HER2-protein expression and HER2-gene amplification by fluorescence in situ hybridization while in literature this tumor is reported to show mainly triple-negative basal type immunophenotype. Conclusion A combined clinic-radio-immunohistochemical approach is essential to make a diagnosis of primary mucinous cystadenocarcinoma.

Keywords